Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Probiotic composition and preparation method and application thereof

A composition and technology of probiotics, applied in the field of probiotics, can solve the problems of no obvious effect and ineffective effect of constipation treatment, and achieve the effect of alleviating constipation, taking into account product efficacy and cost control

Active Publication Date: 2021-07-23
SIRIO PHARMA CO LTD
View PDF14 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Martoni et al. for Lactobacillus acidophilus DDS-1, Bifidobacterium animalis subsp. Bacillus UABb-10 probiotics were clinically studied and found that these four probiotics had no significant effect on the treatment of constipation compared with the placebo group
Ibarra et al. studied the effect of bifidobacterium lactis subspecies HN019 on functional constipation, and found that it had no significant effect on the treatment of constipation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Probiotic composition and preparation method and application thereof
  • Probiotic composition and preparation method and application thereof
  • Probiotic composition and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1: the preparation of probiotic composition product

[0039] The preparation method of probiotic composition product:

[0040] Probiotic composition 1 was prepared by using bacterial powder, Bifidobacterium adolescentis CCFM626: Bifidobacterium breve CCFM622: Bifidobacterium animalis BB-115=2:1:1.

[0041] Use bacterial powder, Lactobacillus reuteri LR-168: Lactobacillus acidophilus LA-99: Bifidobacterium animalis BB-115=4:3:3, namely 40%, 30%, 30%, to prepare probiotic composition 2.

[0042] Mix Lactobacillus reuteri LR-168, Lactobacillus acidophilus LA-99 and Bifidobacterium animalis BB-115 uniformly according to the contents shown in Table 1 to prepare probiotic composition 3, wherein Reuteri Lactobacillus LR-168: Lactobacillus acidophilus LA-99: Bifidobacterium animalis BB-115=2:1:1.

[0043] Table 1

[0044]

[0045]

Embodiment 2

[0046] Embodiment 2: the in vivo effect of probiotic composition product

[0047] Experimental subjects: 6-week-old male SPF grade BABL / c mice.

[0048] Execution standard: The animal experiment protocol was approved by the Ethics Committee of Jiangnan University (JN.No20190930b0501220, JN.No20191115b0500110), and implemented in accordance with the EU guidelines (2010 / 63 / EU).

[0049] Experimental design: 70 mice were randomly assigned to blank group, model group, positive control group, 1-fold group-probiotic composition 3, 10-fold-group probiotic composition 3, probiotic composition 1 group, probiotic combination 2 groups of substances, 10 mice in each group, the ingredients and dosage of the test substances given to the mice in each group are shown in Table 2 below.

[0050] The test substance in the bacterium filling group was the probiotic composition product prepared in Example 1.

[0051] Table 2: Components and dosage of test substances given to mice in each group

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a probiotic composition and a preparation method and application thereof. The probiotic composition comprises raw materials of lactobacillus reuteri, lactobacillus acidophilus and bifidobacterium animalis, wherein the weight ratio of the lactobacillus reuteri to the lactobacillus acidophilus to the bifidobacterium animalis is (1.5-2.5):(0.5-1.5):(0.5-1.5). The colony forming units of the lactobacillus reuteri, the lactobacillus acidophilus or the bifidobacterium animalis in unit weight are the same. The lactobacillus reuteri is preserved in China Center for Type Culture Collection with the preservation number of 209138, and the lactobacillus acidophilus and / or the bifidobacterium animalis preserved in China General Microbiological Culture Collection Center with the preservation number of CGMCC 15210 are / is bifidobacterium animalis BB-115. The probiotic composition can relieve the symptom of slow transit constipation under the condition of low dosage, and can remarkably and effectively regulate gastrointestinal regulatory peptide indexes related to constipation, such as P substance (SP), gastrin (Gas) and vasoactive peptide (VIP).

Description

technical field [0001] The invention relates to the field of probiotics, in particular to a probiotic composition for treating intestinal diseases. Background technique [0002] Constipation is a phenomenon in which stools are hard or dry and difficult to pass, with fewer frequent bowel movements. Constipation is mostly caused by lack of dietary fiber. The onset of some constipation is related to intestinal microorganisms, such as bifidobacteria, which play an important role in maintaining normal intestinal peristalsis. Long-term constipation will cause a large amount of harmful substances in the feces to repeatedly stimulate the intestinal wall, which may cause rectal cancer. Therefore, long-term habitual constipation is not a normal performance and should be given attention. Some people use laxatives to fight constipation but make their condition worse, and the constipation becomes more and more frequent. [0003] Probiotics are live bacteria. They are bacteria that c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/20A23L33/135A61K35/747A61K35/745A61P1/14A61P1/10C12R1/01C12R1/225C12R1/23
CPCC12N1/20A23L33/135A61K35/747A61K35/745A61P1/14A61P1/10A23V2002/00A23V2400/113A23V2400/173A23V2400/515A23V2200/3204A61K2300/00
Inventor 黄桂霞甘聃张万祥
Owner SIRIO PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com